We are live on
!
Find out more
Squarepoint Portfolio holdings
AUM
$85.1B
1-Year Est. Return
20.93%
This Fund
S&P 500
This Quarter
Est. Return
+7.16%
1 Year Est. Return
+20.93%
3 Year Est. Return
+51.38%
5 Year Est. Return
+34.63%
10 Year Est. Return
+146.23%
AUM
$7.42B
AUM Growth
+$1.24B
(+20%)
Cap. Flow
+$985M
Cap. Flow
% of AUM
13.27%
Top 10 Holdings %
Top 10 Hldgs %
10.68%
Holding
3,037
New
854
Increased
791
Reduced
777
Closed
600
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$49.3M |
| 2 |
Intuit
INTU
|
+$48.7M |
| 3 |
Costco
COST
|
+$47.9M |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$47.4M |
| 5 |
Vanguard Real Estate ETF
VNQ
|
+$45.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$41M |
| 2 |
Dollar General
DG
|
+$39M |
| 3 |
Biogen
BIIB
|
+$36.8M |
| 4 |
iShares US Real Estate ETF
IYR
|
+$29.8M |
| 5 |
Waste Management
WM
|
+$29.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.19% |
| 2 | Consumer Discretionary | 16.12% |
| 3 | Healthcare | 11.21% |
| 4 | Financials | 10.17% |
| 5 | Industrials | 9.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1626
Kornit Digital
KRNT
$706M
| $388K | 0.01% |
5,979
-13,692
| -70% | -$785K |
|
1627
Renasant Corp
RNST
$4.01B
| $388K | 0.01% |
17,071
+1,912
| +13% | +$46K |
|
1628
Colliers International
CIGI
$4.98B
| $384K | 0.01% |
5,755
-1,353
| -19% | -$82.2K |
|
1629
Central Garden & Pet Co Class A
CENTA
$2.41B
| $383K | 0.01% |
13,250
+5,591
| +73% | +$161K |
|
1630
Quaker Houghton
KWR
$2.63B
| $383K | 0.01% |
+2,130
| New | +$409K |
|
1631
CALL
International Paper
IP
$22.3B
| $381K | 0.01% |
+9,926
| New | +$350K |
|
|
1632
PUT
International Paper
IP
$22.3B
| $381K | 0.01% |
+9,926
| New | +$350K |
|
|
TELL
1633
DELISTED
Tellurian Inc.
TELL
| $381K | 0.01% |
477,987
-47,879
| -9% | -$44.7K |
|
|
SP
1634
DELISTED
SP Plus Corporation
SP
| $380K | 0.01% |
+21,182
| New | +$389K |
|
|
CBAY
1635
DELISTED
Cymabay Therapeutics
CBAY
| $380K | 0.01% |
52,501
-220,671
| -81% | -$1.18M |
|
1636
ArcelorMittal
MT
$50.4B
| $379K | 0.01% |
+28,607
| New | +$345K |
|
1637
Diodes
DIOD
$4B
| $377K | 0.01% |
6,681
-1,930
| -22% | -$97.7K |
|
|
YALA
1638
Yalla Group
YALA
$786M
| $375K | 0.01% |
+53,500
| New | +$375K |
|
1639
NN Inc
NNBR
$272M
| $374K | 0.01% |
+72,556
| New | +$383K |
|
1640
Vital Farms
VITL
$558M
| $374K | 0.01% |
+9,219
| New | +$348K |
|
1641
Amkor Technology
AMKR
$16.1B
| $372K | 0.01% |
33,227
-59,725
| -64% | -$740K |
|
1642
Canadian Imperial Bank of Commerce
CM
$107B
| $372K | 0.01% |
+9,960
| New | +$365K |
|
1643
Dow Inc
DOW
$21.6B
| $372K | 0.01% |
+7,900
| New | +$355K |
|
1644
McEwen Inc
MUX
$1.03B
| $372K | 0.01% |
35,089
-15,131
| -30% | -$183K |
|
1645
S&T Bancorp
STBA
$1.86B
| $371K | 0.01% |
21,000
+1,242
| +6% | +$25.9K |
|
1646
Mustang Bio
MBIO
$4.26M
| $370K | 0.01% |
157
+88
| +128% | +$217K |
|
1647
Korn Ferry
KFY
$3.98B
| $368K | 0.01% |
+12,697
| New | +$375K |
|
|
ARCH
1648
DELISTED
Arch Resources, Inc.
ARCH
| $368K | 0.01% |
8,661
-12,880
| -60% | -$457K |
|
1649
FerroAtlántica
GSM
$628M
| $367K | ﹤0.01% |
548,821
+501,477
| +1,059% | +$266K |
|
|
MRSN
1650
DELISTED
Mersana Therapeutics
MRSN
| $367K | ﹤0.01% |
788
-250
| -24% | -$126K |
|
Similar funds
Squarepoint's Q3 2020 Portfolio in Review
As of Q3 2020, Squarepoint held 3,037 positions worth $7.42B, up 20% from $6.18B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Squarepoint deployed $985M of net new capital in Q3 2020, opening 854 new positions and adding to 791 existing holdings. Its largest new stake was Salesforce: 186,017 shares worth $46.8M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was Pfizer, an estimated $41M trimmed.
- Squarepoint's largest Q3 2020 buy was Salesforce: 186,017 shares worth $46.8M.
- Squarepoint added most to Visa in Q3 2020, an estimated $49.3M increase.
- Squarepoint's biggest Q3 2020 reduction was Pfizer, cutting an estimated $41M.
- Squarepoint fully exited Biogen in Q3 2020, selling an estimated $36.8M.
- Squarepoint's ten largest holdings make up 11% of its $7.42B portfolio in Q3 2020.
- Squarepoint opened 854 new positions and closed 600 in Q3 2020.
- Squarepoint's portfolio value rose 20% quarter-over-quarter to $7.42B.
Based on Squarepoint's 13F filing for Q3 2020, filed 16 Nov 2020.